Volume 192, number 11: Schistosomiasis and HIV-1 Infection in Rural Zimbabwe: Effect of Treatment of Schistosomiasis on CD4 Cell Count and Plasma HIV-1 RNA Load
3rd Nov 2005, 22:05 GMT
To determine whether treatment of schistosomiasis has an effect on the course of human immunodeficiency virus type 1 (HIV-1) infection, individuals with schistosomiasis and with or without HIV-1 infection were randomized to receive praziquantel treatment at inclusion or after a delay of 3 months; 287 participants were included in the study, and 227 (79%) were followed up. Among the 130 participants who were coinfected, those who received early treatment ([FORMULA]) had a significantly lower increase in plasma HIV-1 RNA load than did those who received delayed treatment ([FORMULA]) ([FORMULA]); this difference was associated with no change in plasma HIV-1 RNA load in the early intervention group ([FORMULA]) and an increase in plasma HIV-1 RNA load in the delayed intervention group ([FORMULA]). Among the 227 participants who were followed up, those who received early treatment ([FORMULA]) had an increase in CD4 cell count, whereas those who received delayed treatment ([FORMULA]) did not ([FORMULA]); this effect did not differ between participants when stratified by HIV-1 infection status ([FORMULA]). The present study suggests that treatment of schistosomiasis can reduce the rate of viral replication and increase CD4 cell count in the coinfected host.
Volume 192, number 11: Schistosomiasis and HIV-1 Infection in Rural Zimbabwe: Effect of Treatment of Schistosomiasis on CD4 Cell Count and Plasma HIV-1 RNA Load related news:
- The reason why antiviral therapy can't annihilate HIV infection, and what to do about it — EurekAlert! - Infectious and Emerging Diseases
- Volume 192, number 11: Influence of HIV Infection on Changes in Circulating Leukocyte Counts during Measles in Zambian Children — J Infect Dis Latest Issue
- Influence of HIV Infection on Changes in Circulating Leukocyte Counts during Measles in Zambian Children — J Infect Dis Latest Articles
- Cheap, rapid hand-held check for HIV — EurekAlert! - Technology, Engineering and Computer Science
- Volume 192, number 11: Parasitological Rebound Effect and Emergence of Pyrimethamine Resistance in Plasmodium falciparum after Single-Dose Sulfadoxine-Pyrimethamine — J Infect Dis Latest Issue
- Volume 192, number 11: Risk Factors for Perinatal Transmission of Hepatitis C Virus (HCV) and the Natural History of HCV Infection Acquired in Infancy — J Infect Dis Latest Issue
- Malawi: Pediatric Antiretroviral Treatment A Must — AllAfrica News: HIV-Aids and STDs
- South Africa: Rural Eastern Cape Aids Treatment Reports Success — AllAfrica News: Health and Medicine
- Zimbabwe: Risk of HIV Infection in Married People High - Study — AllAfrica News: Health and Medicine
- Volume 192, number 11: Simultaneous Generation of Cytomegalovirus-Specific CD8+ and CD4+ T Lymphocytes by Use of Dendritic Cells Comodified with pp65 mRNA and pp65 Protein — J Infect Dis Latest Issue
Latest news from J Infect Dis Latest Issue:
- Volume 194, number 12: Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector
- Volume 194, number 12: Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 DNA Candidate Vaccine
- Volume 194, number 12: Quantification of Viral Inactivation by Photochemical Treatment with Amotosalen and UV A Light, Using a Novel Polymerase Chain Reaction Inhibition Method with Preamplification
- Volume 194, number 12: Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV-1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138
- Volume 194, number 12: Evaluation of Purified Taenia solium Glycoproteins and Recombinant Antigens in the Serologic Detection of Human and Swine Cysticercosis
- Volume 194, number 12: Phase 1 Clinical Trials of the National Institutes of Health Vaccine Research Center HIV/AIDS Candidate Vaccines
- Volume 194, number 12: Is There a Safe Age for Vaccinating Infants with Tetravalent Rhesus-Human Reassortant Rotavirus Vaccine?
- Volume 194, number 12: Reply to Gargiullo et al.
- Volume 194, number 12: Is Panton-Valentine Leukocidin the Major Virulence Determinant in Community-Associated Methicillin-Resistant Staphylococcus aureus Disease?
- Volume 194, number 12: Human Cytolytic T Cell Recognition of Yersinia pestis Virulence Proteins That Target Innate Immune Responses